Search For "cova"
DCGI gives emergency use authorisation to Covaxin for 6-12 age group
Updated : 3 years, 10 months ago IST
New Delhi [India], April 26 (ANI): The Drugs Controller General of India (DCGI) gives restricted emergency use authorisation to Covaxin for the 6-12 age group.
Read More
Bharat Biotech asked to provide more data on COVID-19 vaccine Covaxin for
Updated : 3 years, 10 months ago IST
New Delhi [India], April 22 (ANI): The Subject Expert Committee (SEC) of the Drug Controller General of India (DCGI) has asked Bharat Biotech for additional data on its COVID-19 vaccine, Covaxin, for administering it to children aged between 2-12 years, sources said.
Read More
Expert panel of DCGI holds meet to discuss recommendations to use COVID-19
Updated : 3 years, 10 months ago IST
New Delhi [India], April 21 (ANI): The meeting of the Subject Expert Committee (SEC) of the Drug Controller General of India (DCGI) is underway to discuss recommendations on restricted emergency use of Bharat Biotech's Covaxin and Biological E's Corbevax COVID-19 vaccine for children aged
Read More
Ocugen to commercialize Covaxin in Mexico, rights now encompassing all of
Updated : 3 years, 11 months ago IST
Malvern (Pennsylvania) [US]/ Hyderabad (Telangana) [India], April 18 (ANI): Biotechnology company Ocugen and Bharat Biotech (BBIL), on Monday, announced that they have entered into an amendment to their Co-development, Supply and Commercialization Agreement to expand Ocugen's exclusive terri
Read More
Indian COVID vaccines better than Pfizer, Moderna says Adar Poonawalla
Updated : 3 years, 11 months ago IST
New Delhi [India], April 13 (ANI): Serum Institute of India (SII) CEO Adar Poonawalla on Wednesday claimed that "Made in India" COVID-19 vaccines have provided more protection against the coronavirus infection than mRNA vaccines like Pfizer and Moderna.
Read More
COVID vaccine: Covaxin price reduced from Rs 1,200 to Rs 225 per dose for
Updated : 3 years, 11 months ago IST
Hyderabad (Telangana) [India], April 9 (ANI): Welcoming the decision to make precautionary dose available for all adults, Hyderabad-based vaccine manufacturer Bharat Biotech on Saturday, announced that it has revised the price of its COVID vaccine Covaxin from Rs 1,200 to Rs 225 per dose for
Read More
Covaxin supply suspension by WHO not to impact travel by people: MEA
Updated : 3 years, 11 months ago IST
New Delhi [India], April 8 (ANI): World Health Organization (WHO) suspending the supply of Covaxin through UN procurement agencies over "process and facility upgrade" requirements will not have an impact on travel by those who have taken the COVID vaccine, Ministry of External Affairs said o
Read More
Japan recognizes India's COVAXIN to facilitate travel between both countri
Updated : 3 years, 11 months ago IST
Tokyo [Japan], April 7 (ANI): Japan recognizes India's COVID-19 vaccine COVAXIN manufactured by Bharat Biotech with effect from April 10 to further facilitate travel from India to Japan, said the Indian Embassy in Japan on Thursday.
Read More
Bharat Biotech to rectify issues raised by WHO on Covaxin soon: Sources
Updated : 3 years, 11 months ago IST
New Delhi [India], April 4 (ANI): Hyderabad-based pharmaceutical company, Bharat Biotech will rectify the issues raised by the World Health Organization regarding its COVID-19 vaccine-- Covaxin-- in a few days and added that the company has informed about this development to the Drugs Con
Read More
WHO suspension for Covaxin supply only for UN agencies: Sources
Updated : 3 years, 11 months ago IST
New Delhi [India], April 4 (ANI): The World Health Organization's (WHO) suspension of supplies of Covaxin of the Bharat Biotech supply is not related to safety or efficacy issues but only to supply for United Nations agencies, sources said.
Read More
No impact on efficacy and safety of Covaxin: Bharat Biotech after WHO susp
Updated : 3 years, 11 months ago IST
Hyderabad (Telangana)[India], April 3 (ANI): Hyderabad-based Bharat Biotech on Sunday issued a clarification that there is "no impact on efficacy and safety of the COVID-19 vaccine COVAXIN" after the World Health Organisation suspended it from its Covax facility.
Read More
Bharat Biotech temporarily slows down COVAXIN production for facility opti
Updated : 3 years, 11 months ago IST
Hyderabad (Telangana) [India], April 1 (ANI): Bharat Biotech on Friday announced the temporary slowing down of production of COVAXIN across its manufacturing facilities, having completed its supply obligations to procurement agencies and foreseeing the decrease in demand.
Read More